Form 8-K - Current report:
SEC Accession No. 0001193125-21-159837
Filing Date
2021-05-13
Accepted
2021-05-13 07:37:29
Documents
3
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d531458d8k.htm 8-K 17346
2 EX-99.1 d531458dex991.htm EX-99.1 39858
3 GRAPHIC g531458g0513022538467.jpg GRAPHIC 5381
  Complete submission text file 0001193125-21-159837.txt   65873
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 21917228
SIC: 2836 Biological Products, (No Diagnostic Substances)